PF-07817883
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for PF-07817883, covering 2024-09-19 to 2025-02-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn How Renal Impairment Affects the Pharmacokinetics of PF-07817883. [Phase 1]